Hippocampal CA1 Interneurons

Hippocampal CA1 Interneurons

<table class="infobox infobox-celltype">
<tr>
<th class="infobox-header" colspan="2">Hippocampal CA1 Interneurons</th>
</tr>
<tr> [@sst2012]
<td class="label">Allen Atlas ID</td> [@sst2022]
<td><a href="https://portal.brain-map.org/atlases-and-data/rnaseq" target="_blank">CS202210140_3452</a></td> [@vip2016]
</tr> [@compensatory2024]
<tr> [@cck2019]
<td class="label">Lineage</td> [@npy2020]
<td>Neuron > GABAergic > Hippocampal > CA1 interneuron</td> [@feedforward2002]
</tr> [@feedback2014]
<tr> [@theta2015]
<td class="label">Markers</td> [@gamma2016]
<td>GAD1, GAD2, PV, SST, VIP, CCK, CR, NPY</td> [@olm2014]
</tr> [@tau2021]
<tr> [@early2019]
<td class="label">Brain Regions</td> [@network2021]
<td>Hippocampus CA1 stratum radiatum, stratum lacunosum-moleculare, stratum pyramidale</td> [@calcium2019]
</tr> [@metabolic2020]
<tr> [@amyloid2020]
<td class="label">Disease Vulnerability</td> [@tau2022]
<td>[Alzheimer's Disease](/diseases/alzheimers-disease), [Epilepsy](/diseases/epilepsy), [Frontotemporal Dementia](/diseases/ftd)</td> [@neuroinflammation2020]
</tr> [@optogenetic2020]
</table> [@singlecell2018]

Hippocampal CA1 Interneurons

Overview

Hippocampal Ca1 Interneurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

<!-- taxonomy-enrichment -->

...

Hippocampal CA1 Interneurons

<table class="infobox infobox-celltype">
<tr>
<th class="infobox-header" colspan="2">Hippocampal CA1 Interneurons</th>
</tr>
<tr> [@sst2012]
<td class="label">Allen Atlas ID</td> [@sst2022]
<td><a href="https://portal.brain-map.org/atlases-and-data/rnaseq" target="_blank">CS202210140_3452</a></td> [@vip2016]
</tr> [@compensatory2024]
<tr> [@cck2019]
<td class="label">Lineage</td> [@npy2020]
<td>Neuron > GABAergic > Hippocampal > CA1 interneuron</td> [@feedforward2002]
</tr> [@feedback2014]
<tr> [@theta2015]
<td class="label">Markers</td> [@gamma2016]
<td>GAD1, GAD2, PV, SST, VIP, CCK, CR, NPY</td> [@olm2014]
</tr> [@tau2021]
<tr> [@early2019]
<td class="label">Brain Regions</td> [@network2021]
<td>Hippocampus CA1 stratum radiatum, stratum lacunosum-moleculare, stratum pyramidale</td> [@calcium2019]
</tr> [@metabolic2020]
<tr> [@amyloid2020]
<td class="label">Disease Vulnerability</td> [@tau2022]
<td>[Alzheimer's Disease](/diseases/alzheimers-disease), [Epilepsy](/diseases/epilepsy), [Frontotemporal Dementia](/diseases/ftd)</td> [@neuroinflammation2020]
</tr> [@optogenetic2020]
</table> [@singlecell2018]

Hippocampal CA1 Interneurons

Overview

Hippocampal Ca1 Interneurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

<!-- taxonomy-enrichment -->

<!-- multi-taxonomy-enrichment -->

Multi-Taxonomy Classification

Taxonomy Database Cross-References

| Taxonomy | ID | Name / Label |
|----------|----|---------------|
| Cell Ontology (CL) | [CL:4023060](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4023060) | hippocampal CA1-3 neuron |

Morphology & Electrophysiology

• Morphology: hippocampal CA1-3 neuron (source: Cell Ontology)
• Morphology can be inferred from Cell Ontology classification

PanglaoDB Marker Cross-References

• Unknown (PanglaoDB):

External Database Links

• [Cell Ontology (CL:4023060)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4023060)
• [OBO Foundry (CL:4023060)](http://purl.obolibrary.org/obo/CL_4023060)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [Human Cell Atlas](https://www.humancellatlas.org/)
• [PanglaoDB](https://panglaodb.se/)

Taxonomy & Classification

| Database | ID | Name | Confidence |
|----------|----|------|------------|
| Cell Ontology | [CL:4023060](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4023060) | hippocampal CA1-3 neuron | Medium |

PanglaoDB Marker Cross-References

• Unknown (PanglaoDB):

External Database Links

• [Cell Ontology (CL:4023060)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4023060)
• [OBO Foundry (CL:4023060)](http://purl.obolibrary.org/obo/CL_4023060)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [PanglaoDB](https://panglaodb.se/)

Introduction

Hippocampal CA1 Interneurons are a diverse population of GABAergic inhibitory neurons located in the CA1 region of the hippocampus. These cells play critical roles in regulating hippocampal circuit activity, memory consolidation, and spatial navigation. They are characterized by the expression of marker genes including GAD1, GAD2, parvalbumin (PV), somatostatin (SST), vasoactive intestinal peptide (VIP), and cholecystokinin (CCK)^[1].

The CA1 region is particularly vulnerable in Alzheimer's Disease (AD), with CA1 interneurons showing early dysfunction that contributes to memory deficits before overt neuronal loss^[2].

Subtypes and Classification

Hippocampal CA1 interneurons are classified into several major subtypes based on their molecular markers, morphology, and electrophysiological properties:

Parvalbumin (PV+) Interneurons

• Location: Primarily in stratum pyramidale and stratum radiatum
• Morphology: Basket cells and bistratified cells
• Function: Fast-spiking, provide powerful perisomatic inhibition to pyramidal cells
• Role: Critical for gamma oscillations (30-100 Hz) essential for memory consolidation^[3]
• Disease relevance: PV+ interneurons show reduced expression in AD, contributing to network hyperexcitability^[4]

Somatostatin (SST+) Interneurons

• Location: Primarily in stratum radiatum and stratum lacunosum-moleculare
• Morphology: O-LM (oriens-lacunosum moleculare) cells, HIPP cells
• Function: Dendrite-targeting, regulate input integration
• Role: Control of dendritic compartments, memory consolidation, novelty detection^[5]
• Disease relevance: SST+ interneurons are particularly vulnerable in AD and show early tau pathology^[6]

Vasoactive Intestinal Peptide (VIP+) Interneurons

• Location: Throughout CA1 layers
• Morphology: Dendrite-targeting and some perisomatic targeting
• Function: Disinhibition through inhibition of other interneurons
• Role: Regulate information flow during active exploration and learning^[7]
• Disease relevance: VIP+ interneurons may compensate for loss of other subtypes in early AD^[8]

Cholecystokinin (CCK+) Interneurons

• Location: Primarily stratum pyramidale and stratum radiatum
• Morphology: Basket cells, similar to PV+ but with different kinetics
• Function: Moderate-spiking, provide context-dependent inhibition
• Role: Modulation of memory consolidation and recall^[9]

Neuropeptide Y (NPY+) Interneurons

• Location: All CA1 layers
• Morphology: Diverse morphologies
• Function: Slow, sustained inhibition
• Role: Stress response, seizure suppression
• Disease relevance: NPY expression changes in epilepsy and AD^[10]

Normal Circuit Function

Feedforward Inhibition

CA1 interneurons receive excitatory input from CA3 Schaffer collateral axons and entorhinal cortical perforant path inputs. They provide rapid feedforward inhibition to CA1 pyramidal cells, shaping the temporal window for synaptic integration and preventing overexcitation^[11].

Feedback Inhibition

Interneurons receive recurrent excitation from CA1 pyramidal cells, providing feedback inhibition that stabilizes the circuit and prevents runaway excitation^[12].

Theta Oscillations (4-8 Hz)

During spatial navigation and memory formation, hippocampal neurons exhibit theta rhythmic activity. PV+ interneurons are precisely locked to theta cycles, providing phasic inhibition that enables temporal coding of information^[13].

Gamma Oscillations (30-100 Hz)

PV+ basket cell networks generate gamma oscillations through mutual inhibition. Gamma coupling to theta (theta-gamma nesting) is critical for successful memory encoding and retrieval^[14].

Memory Consolidation

SST+ O-LM interneurons specifically inhibit the distal dendrites of CA1 pyramidal cells, effectively blocking entorhinal cortical input during memory consolidation when CA3-driven activity dominates^[15].

Vulnerability in Alzheimer's Disease

Early Pathological Changes

CA1 interneurons show several early changes in AD:

Tau pathology: SST+ interneurons in the stratum lacunosum-moleculare accumulate early tau pathology, particularly in cases with limbic-predominant AD^[16]

PV+ interneuron dysfunction: Reduced PV expression and altered fast-spiking properties precede visible amyloid deposition^[17]

Network hyperexcitability: Loss of inhibitory control leads to hippocampal hyperexcitability, a precursor to epileptiform activity observed in AD patients^[18]

Calcium dysregulation: Interneurons have high calcium buffering requirements; aged and AD brain shows impaired calcium homeostasis^[19]

Mechanisms of Vulnerability

Metabolic Stress

Interneurons have high metabolic demands due to their fast-spiking properties. In AD, compromised cerebral glucose metabolism affects interneurons disproportionately^[20].

Amyloid-β Effects

Aβ directly suppresses GABA release from interneurons and reduces their excitability through multiple mechanisms^[21].

Tau-Mediated Toxicity

Tau pathology spreads through neural circuits, and interneurons may serve as hub cells for tau propagation^[22].

Neuroinflammation

Microglial activation in AD releases cytokines that alter interneuron function and survival^[23].

Therapeutic Implications

• GABAergic enhancement: Benzodiazepines and GABA-A receptor modulators show mixed results in AD
• Targeted interneuron stimulation: Optogenetic activation of PV+ interneurons restores gamma oscillations and memory in mouse models^[24]
• Tau reduction: Reducing tau in interneurons may preserve circuit function
• Anti-inflammatory strategies: Protecting interneurons from neuroinflammation

Transcriptomic Profile

Single-cell RNA sequencing has revealed distinct transcriptomic signatures for each interneuron subtype^[25]:

| Subtype | Key Markers | Enriched Pathways |
|---------|-------------|-------------------|
| PV+ | Pvalb, Gad1, Slc32a1 | GABA synthesis, ion channel activity |
| SST+ | Sst, Gad1, Htr2a | Neuropeptide signaling, calcium signaling |
| VIP+ | Vip, Gad2, Calb2 | Neuropeptide signaling, GPCR pathways |
| CCK+ | Cck, Gad2, Htr3a | Cholecystokinin signaling |
| NPY+ | Npy, Gad1, Penk | Neuropeptide Y signaling |

Key Publications

[Interneuron diversity and dysfunction in Alzheimer's disease (2021)](https://doi.org/10.1038/s41583-021-00450-x). Nature Reviews Neuroscience.

[PV interneuron deficits in AD mouse models (2019)](https://doi.org/10.1016/j.neuron.2019.05.012). Neuron.

[SST interneuron vulnerability in tauopathy (2022)](https://doi.org/10.1038/s41586-022-04413-w). Nature.

[Gamma oscillations restore memory in AD models (2020)](https://doi.org/10.1038/s41586-020-2774-9). Nature.

[Tau pathology in hippocampal interneurons (2021)](https://doi.org/10.1093/brain/awab044). Brain.

External Links

• Allen Cell Type Atlas: [https://portal.brain-map.org/atlases-and-data/rnaseq](https://portal.brain-map.org/atlases-and-data/rnaseq)
• Allen Human Brain Atlas: [https://human.brain-map.org/](https://human.brain-map.org/)
• [Cell Types Index](/cell-types) Hippocampal CA1 Pyramidal Neurons
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• GABAergic Signaling in Neurodegeneration
• Theta-Gamma Coupling
• --

Overview

Hippocampal Ca1 Interneurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Background

The study of Hippocampal Ca1 Interneurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.